ENDPOINT HEALTH Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Endpoint Health is a biotechnology research company based in Palo Alto, California, focused on precision-first therapeutics for immune-mediated chronic and acute diseases. It integrates a proprietary AI platform with companion diagnostics to guide the development of targeted therapies. The goal is to tailor treatments to a patient’s biology and disease, moving beyond generic approaches. In October 2022, Endpoint Health acquired Iconic Therapeutics, broadening its scope into a precision immunology program. That program targets tissue factor-mediated inflammatory signaling to address autoimmune and related inflammatory conditions.